As of May 24
| -0.0199 / -2.19%|
The 1 analysts offering 12-month price forecasts for Lexaria Bioscience Corp have a median target of 2.35, with a high estimate of 2.35 and a low estimate of 2.35. The median estimate represents a +164.04% increase from the last price of 0.89.
The current consensus among 1 polled investment analysts is to Buy stock in Lexaria Bioscience Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.